VRCA is currently covered by 5 analysts with average potential upside of $6.74 (90.86%) backed by 10 price targets and 27 ratings. Documented since 21-Feb-2019. Analyst's average stock valuation to be materialised ratio is 13.33% with an average time for price targets to be met of 82.2 days.
Most recent stock forecast was given by GREGORY RENZA from RBC on 07-Mar-2023.
Highest price target for VRCA is 12, Lowest price target is 2, average price target is 7.
Currently, out of the existing stock ratings of VRCA - 16 which are a Buy (84.21%), 3 which are a Hold (15.79%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
11
$4.47 (68.45%)
11
20 days ago
1/6 (16.67%)
$5.03 (70.26%)
79
Hold
11
$4.47 (68.45%)
4
1 months 14 days ago
1/4 (25%)
$4.51 (64.65%)
79
Buy
12
$5.47 (83.77%)
9 months 24 days ago
0/4 (0%)
$8.54 (183.66%)
Buy
10 months 2 days ago
1/4 (25%)
$8.4 (83.16%)
253
Buy
18
$15.41 (594.98%)
24
1 years 6 months 6 days ago
0/4 (0%)
$7.24 (52.55%)
What is VRCA(Verrica Pharmaceuticals Inc) average time for price targets to be met?
Which analyst has the current highest performing score on VRCA(Verrica Pharmaceuticals Inc) with a proven track record?
